Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001371796-12-000003
Filing Date
2012-03-28
Accepted
2012-03-28 11:03:28
Documents
1
Effectiveness Date
2012-03-28
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7413
  Complete submission text file 0001371796-12-000003.txt   8427
Mailing Address 139 NEWBURY STREET FRAMINGHAM MA 01701
Business Address 139 NEWBURY STREET FRAMINGHAM MA 01701 508-283-1200
Solace Therapeutics Inc (Filer) CIK: 0001371796 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-175724 | Film No.: 12719391